The latest in neuroscience—sorted and summarized for you
Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by —your source for peer-reviewed, evidence-based information. Innovations in Clinical Neuroscience This week’s topic: Rapid-acting Antidepressants
Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants
Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy
Neurobiology of Stress, Depression, and Rapid Acting Antidepressants: Remodeling Synaptic Connections
Circadian Dysregulation of Clock Genes: Clues to Rapid Treatments in Major Depressive Disorder
Ketamine and Other N-methyl-D-aspartate Receptor Antagonists in the Treatment of Depression: A Perspective Review
Scientists Seek Fast-acting Antidepressant, from Ketamine to Laughing Gas
Five New NMDA Receptor (Glutamate) Modulators For Depression
R apastinel: A Novel Approach to Depression?
The Search for a “Safer” Ketamine
Novel Route for Ketamine in the Treatment of MDD
20 New Antidepressants In The Pipeline (2015): Drugs In Clinical Trials
Depression: My Story About the Power of Medication
Why We’ve Probably Overestimated the Benefits of Psychotherapy for Depression
The Mental Illness Drunk Tank
Ketamine: Life Saver or Club Drug?
Have a great week!
Category: Drug Development, Mood Disorders, Psychiatry, Psychopharmacology, The Neuroscience Report